China Releases Follow-Up Tariff Exclusion List for US$60bn Worth US Imports

Posted by Written by Zoey Zhang Reading Time: < 1 minute

On May 12, 2020, the Tariff Commission of the State Council of China released the Notice on the Second-time Exclusion of the Second Batch of Goods Subject to Tariffs Imposed on the US Imports (Tariff Commission Announcement [2020] No.4).

According to the Notice, a list of 79 US imports will be eligible for waivers from China’s retaliatory tariffs, including products like medical disinfectants, rare earth ores, silver and gold ores, concentrates, some nickel, aluminum alloy products etc. The tariff waiver will take effect from May 19, 2020 to May 20, 2021.


The ink on the Phase One trade deal was barely dry before a global pandemic broke out, find out how Covid-19 might affect the deal.

For the refund of the tariffs already paid, the relevant import enterprises will need to apply to Customs for refund processing within six months from the date of the promulgation of the exclusion list.

The exclusion list is the second-time exclusion for the second batch of US imports worth US$60 billion that have been subject to China’s additional tariffs since September 2018 (see Tariff Commission Announcement [2018] No.6). Previously, on February 21, 2020, the Tariff Commission announced the first-time exclusion for this batch of US products, which included two lists (see Tariff Commission Announcement [2020] No.3, list 1 and list 2). Other goods of the second batch of US imports that are not covered by the above-mentioned exclusion lists – will still be subject to tariff rates of 5, 10, 20, and 25 percent.

About Us

China Briefing is written and produced by Dezan Shira & Associates. The practice assists foreign investors into China and has done so since 1992 through offices in Beijing, Tianjin, Dalian, Qingdao, Shanghai, Hangzhou, Ningbo, Suzhou, Guangzhou, Dongguan, Zhongshan, Shenzhen, and Hong Kong. Please contact the firm for assistance in China at

We also maintain offices assisting foreign investors in Vietnam, Indonesia, Singapore, The Philippines, MalaysiaThailand, United States, and Italy, in addition to our practices in India and Russia and our trade research facilities along the Belt & Road Initiative.